Phosphorylation State-Dependent High Throughput Screening of the c-Met Kinase.

about

Phosphorylation State-Dependent High Throughput Screening of the c-Met Kinase.

Item

http://www.wikidata.org/entity/Q41065661

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Phosphorylation State-Dependent High Throughput Screening of the c-Met Kinase.

@en

type

Item

label

Phosphorylation State-Dependent High Throughput Screening of the c-Met Kinase.

@en

prefLabel

Phosphorylation State-Dependent High Throughput Screening of the c-Met Kinase.

@en

P1476

Phosphorylation State-Dependent High Throughput Screening of the c-Met Kinase.

@en

P2093

Alexander Margulis

http://www.w3.org/2001/XMLSchema#string

Elham Behshad

http://www.w3.org/2001/XMLSchema#string

Gregory F Hollis

http://www.w3.org/2001/XMLSchema#string

Mark J Rupar

http://www.w3.org/2001/XMLSchema#string

Mary Becker-Pasha

http://www.w3.org/2001/XMLSchema#string

Paul Collier

http://www.w3.org/2001/XMLSchema#string

Phillip C Liu

http://www.w3.org/2001/XMLSchema#string

Richard Wynn

http://www.w3.org/2001/XMLSchema#string

Ronald M Klabe

http://www.w3.org/2001/XMLSchema#string

Timothy C Burn

http://www.w3.org/2001/XMLSchema#string

P2860

Structural characterization of autoinhibited c-Met kinase produced by coexpression in bacteria with phosphatase.

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)

c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations

KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients

The conformational plasticity of protein kinases

Crystal structures of the phosphorylated and unphosphorylated kinase domains of the Cdc42-associated tyrosine kinase ACK1

Protein kinases--the major drug targets of the twenty-first century?

Rational design of inhibitors that bind to inactive kinase conformations

High throughput screening for protein kinase inhibitors.

P304

27-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1875397301004010027

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44681022

http://www.w3.org/2001/XMLSchema#string

P698

20556206

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

2885599

http://www.w3.org/2001/XMLSchema#string